Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Ex vivo nanofiber expansion and genetic modification of human cord blood-derived progenitor/stem cells enhances vasculogenesis.

Cell transplantation - 1 Jan 2009

Das Hiranmoy, Abdulhameed Nasreen, Joseph Matthew, Sakthivel Ramasamy, Mao Hai-Quan, Pompili Vincent J

Abstract excerpt

The stem cell therapy for treating ischemic diseases is promising; however, the limited availability and compromised quality of progenitor cells in aged and diseased patients limit its therapeutic use. Here we report a nanofiber-based ex vivo stem cell expansion technology and proangiogenic growt...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Vessels
Share to Cord Blood Stem Cell Transplantation
Share to Fetal Blood

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hindlimb

Share to Ischemia

Share to Nanostructures

Share to Organogenesis

Share to Platelet-Derived Growth Factor

Source

Open in PubMed Open full text

Identifiers

PMID: 19558779
DOI: 10.3727/096368909788534870
PMCID: PMC2749501

Genes

CXCR4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19558779-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Ex vivo nanofiber expansion and genetic modification of human cord blood-derived progenitor/stem cells enhances vasculogenesis.PMID 19558779Read ↗

Retention of stemness and vasculogenic potential of human umbilical cord blood stem cells after repeated expansions on PES-nanofiber matrices.Semantic proximity Read ↗

Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration.Semantic proximity Read ↗

CH02 Peptide Promotes CD34+ Umbilical Cord Blood Hematopoietic Stem Cells Ex Vivo ExpansionSemantic proximity Read ↗

Angiogenic cell therapy for critical limb ischemia: an update on concepts and trials.Semantic proximity Read ↗

Therapeutic ability of extracellular vesicles derived from angio-miRNA-modified mesenchymal stromal cells in ischemic animal modelsSemantic proximity Read ↗

Vascular regeneration and skeletal muscle repair induced by long-term exposure to SDF-1α derived from engineered mesenchymal stem cells after hindlimb ischemiaSemantic proximity Read ↗

Tissue-engineered microvessels on three-dimensional biodegradable scaffolds using human endothelial progenitor cells.Semantic proximity Read ↗

Arterial endothelium creates a permissive niche for expansion of human cord blood hematopoietic stem and progenitor cellsSemantic proximity Read ↗

Vascular engineering using human embryonic stem cellsSemantic proximity Read ↗

Fascia-Derived Stem Cells Enhance Fat Graft Retention by Promoting Vascularization through the HMOX1-HIF-1α PathwaySemantic proximity Read ↗

Growth of outgrowth endothelial cells on aligned PLLA nanofibrous scaffolds.Semantic proximity Read ↗

Nanofiber-Based in Vitro System for High Myogenic Differentiation of Human Embryonic Stem CellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.